As the moon shines brighter, and hearts grow lighter, our sincere Raya wish is for blessings to flourish. May you have a warm and joyous celebration. Selamat Hari Raya Aidilfitri!
--
Kindly be informed that we are closed from 05-06-2019 (Wed) to 06-06-2019 (Thurs) and will resume operation on 07-06-2019 (Fri). Please call us at +603 5525 1356 for any inquires! Thank you.
... See MoreSee Less

As the moon shines brighter, and hearts grow lighter, our sincere Raya wish is for blessings to flourish. May you have a warm and joyous celebration. Selamat Hari Raya Aidilfitri!
--
Kindly be informed that we are closed from 05-06-2019 (Wed) to 06-06-2019 (Thurs) and will resume operation on 07-06-2019 (Fri). Please call us at +603 5525 1356 for any inquires! Thank you.

Oncode received the Certificate of Participation from United Kingdom National External Quality Assessment Service (UKNEQAS) for Leucocyte Immunophenotyping molecular tests on acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasm (MPN) and hairy cell leukemia.

Since 1991 UK NEQAS for Leucocyte Immunophenotyping has provided External Quality Assessment (EQA) to laboratories within the UK and Internationally. The findings from the programmes ensure that clinical laboratory tests on patients are robust, accurate, precise and therefore clinically of value, regardless of the location they are performed. Furthermore, they contribute towards the production of international and national guidelines and underpin the generation of local clinical laboratory results for use in the diagnosis and monitoring of patients throughout their treatment journeys. The services provided by UK NEQAS for Leucocyte Immunophenotyping are operated on a global scale, with laboratories participating from over 80 countries.
... See MoreSee Less

Oncode received the Certificate of Participation from United Kingdom National External Quality Assessment Service (UKNEQAS) for Leucocyte Immunophenotyping molecular tests on acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), myeloproliferative neoplasm (MPN) and hairy cell leukemia. 

Since 1991 UK NEQAS for Leucocyte Immunophenotyping has provided External Quality Assessment (EQA) to laboratories within the UK and Internationally. The findings from the programmes ensure that clinical laboratory tests on patients are robust, accurate, precise and therefore clinically of value, regardless of the location they are performed. Furthermore, they contribute towards the production of international and national guidelines and underpin the generation of local clinical laboratory results for use in the diagnosis and monitoring of patients throughout their treatment journeys. The services provided by UK NEQAS for Leucocyte Immunophenotyping are operated on a global scale, with laboratories participating from over 80 countries.

 

Comment on Facebook

Wooww congratulations 2 Oncode Gd job & well done๐Ÿ‘๐Ÿป๐Ÿ™๐Ÿป๐Ÿ˜ƒ

Well done. ๐Ÿ‘๐Ÿ‘๐Ÿ‘

A very good wish and greetings to all the workers throughout the world on this May day. We are close today! ๐Ÿฅณ ... See MoreSee Less

A very good wish and greetings to all the workers throughout the world on this May day. We are close today! ๐Ÿฅณ
Load more